Mesalamine - NDC Database

86 records found

Page:1

0430-0783 May 28, 2008
Asacol Hd 800 mg Delayed Release Tablet by Warner Chilcott (Us), LLC

60687-347 Jan 02, 2018
Mesalamine 800 mg Oral Tablet, Delayed Release by American Health Packaging

60687-397 Oct 11, 2018
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by American Health Packaging

0023-5901 May 28, 2008
Asacol Hd 800 mg Oral Tablet, Delayed Release by Allergan, Inc.

16714-830 Jun 25, 2018
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Northstar Rx LLC.

50090-3497 Aug 01, 2016
Mesalamine 800 mg Oral Tablet, Delayed Release by A-s Medication Solutions

60687-264 Nov 18, 2016
Mesalamine 800 mg Oral Tablet, Delayed Release by American Health Packaging

68382-484 Aug 01, 2016
Mesalamine 800 mg Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.

68382-649 Aug 01, 2016
Mesalamine 800 mg Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.

68382-711 Jun 19, 2017
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Zydus Pharmaceuticals (Usa) Inc.

70771-1071 Jun 19, 2017
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Cadila Healthcare Limited

0037-0022 Mar 29, 2016
Sfrowasa 4 g/60ml Rectal Suspension by Meda Pharmaceuticals

0093-5907 May 09, 2019
Mesalamine 400 mg Oral Capsule, Delayed Release by Teva Pharmaceuticals USA, Inc.

0093-9224 Jan 05, 2021
Mesalamine 375 mg Oral Capsule, Extended Release by Teva Pharmaceuticals USA, Inc.-

0378-1375 Nov 26, 2019
Mesalamine .375 g/1 Oral Capsule, Extended Release by Mylan Pharmaceuticals Inc.

0378-7401 Dec 14, 2018
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Mylan Pharmaceuticals Inc.

0378-9230 Dec 17, 2018
Mesalamine 1000 mg Rectal Suppository by Mylan Pharmaceuticals Inc.

0472-1915 Apr 23, 2021
Mesalamine 1000 mg Rectal Suppository by Actavis Pharma, Inc.

0480-7750 Aug 22, 2024
Mesalamine 800 mg Oral Tablet, Delayed Release by Teva Pharmaceuticals, Inc.

0527-3012 Jun 03, 2023
Mesalamine 1.2 g/1 Oral Tablet, Delayed Release by Lannett Company Inc.

Page:1

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.